Soaanz is a loop diuretic with an extended duration of action lasting approximately 6 to 8 hours. The Food and Drug Administration (FDA) has approved Soaanz ® (torsemide) for the treatment of edema ...
Edema and fluid overload remain the leading causes of hospitalization and readmission for patients with CHF, cirrhosis, and chronic kidney disease. An estimated 6.7 million Americans live with heart ...
SUBCUT HF II, a randomized controlled investigator-sponsored trial of at-home subcutaneous furosemide for heart failure–related edema, meets its primary and key secondary endpoints, supporting the ...
Soaanz is a loop diuretic with an extended duration of action lasting approximately 6 to 8 hours. The Food and Drug Administration (FDA) has approved Soaanz ® (torsemide) for the treatment of edema ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results